These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9621691)

  • 21. [Interchangeability of mutagens during fractionated effects of unequal concentrations of alkylating agents].
    Tulina AN; Chebotarev AN
    Biull Eksp Biol Med; 1989 Jul; 108(7):79-81. PubMed ID: 2508787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro antiviral effect of extracts of Kuehneromyces mutabilis on influenza virus.
    Mentel R; Meinsen D; Pilgrim H; Herrmann B; Lindequist U
    Pharmazie; 1994 Nov; 49(11):859-60. PubMed ID: 7838873
    [No Abstract]   [Full Text] [Related]  

  • 23. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs.
    Govorkova EA; Kodihalli S; Alymova IV; Fanget B; Webster RG
    Dev Biol Stand; 1999; 98():39-51; discussion 73-4. PubMed ID: 10494958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Avian influenza vaccines and therapies for poultry.
    Swayne DE
    Comp Immunol Microbiol Infect Dis; 2009 Jul; 32(4):351-63. PubMed ID: 18442853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inactivated influenza virus vaccines in children.
    Ruben FL
    Clin Infect Dis; 2004 Mar; 38(5):678-88. PubMed ID: 14986252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques.
    Itoh Y; Ozaki H; Tsuchiya H; Okamoto K; Torii R; Sakoda Y; Kawaoka Y; Ogasawara K; Kida H
    Vaccine; 2008 Jan; 26(4):562-72. PubMed ID: 18164788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of the host cell on standardisation of influenza vaccine potency.
    Wood JM; Dunleavy U; Newman RW; Riley AM; Robertson JS; Minor PD
    Dev Biol Stand; 1999; 98():183-8; discussion 197. PubMed ID: 10494972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral activity of Arthrospira-derived spirulan-like substances.
    Rechter S; König T; Auerochs S; Thulke S; Walter H; Dörnenburg H; Walter C; Marschall M
    Antiviral Res; 2006 Dec; 72(3):197-206. PubMed ID: 16884788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic analysis reveals that both haemagglutinin and neuraminidase determine the sensitivity of naturally occurring avian influenza viruses to zanamivir in vitro.
    Baigent SJ; Bethell RC; McCauley JW
    Virology; 1999 Oct; 263(2):323-38. PubMed ID: 10544106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemical inactivation of retroviral infectivity by targeting nucleocapsid protein zinc fingers: a candidate SIV vaccine.
    Arthur LO; Bess JW; Chertova EN; Rossio JL; Esser MT; Benveniste RE; Henderson LE; Lifson JD
    AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S311-9. PubMed ID: 9814959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antiviral and antitumor activity of modified catecholamines].
    Potopal'skiĭ AI; Loziuk LV; Ivasivka SV; Semeniuk TN; Gara'ko SI
    Mikrobiol Zh (1978); 1983; 45(1):76-80. PubMed ID: 6406801
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antiviral activity of pentaene macrolides].
    Shtil'bans EB
    Tr Inst Im Pastera; 1982; 58():131-4. PubMed ID: 6316588
    [No Abstract]   [Full Text] [Related]  

  • 33. Mutations of neuraminidase implicated in neuraminidase inhibitors resistance.
    Ferraris O; Lina B
    J Clin Virol; 2008 Jan; 41(1):13-9. PubMed ID: 18055254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro antiviral activity of antisense oligonucleotides against influenza virus].
    Chen Z; Wang S; Guan W; Yang B; Sun Z
    Wei Sheng Wu Xue Bao; 2000 Oct; 40(5):482-7. PubMed ID: 12548758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulatory perspective in the United States on cell cultures for production of inactivated influenza virus vaccines.
    Levandowski RA
    Dev Biol Stand; 1999; 98():171-5; discussion 197. PubMed ID: 10494970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiviral effects of rhIFN-alpha 1 against seven influenza viruses.
    Li F; Wang QJ; Zhu BL; Wang M
    Zhongguo Yao Li Xue Bao; 1999 Aug; 20(8):709-14. PubMed ID: 10678103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of L-lysine-a-oxidase on reproduction of herpes simplex type I virus in vitro].
    Smirnova IP; Diorditsa SV; Alekseev SB; Zaĭtsev IZ
    Vopr Med Khim; 1998; 44(4):384-7. PubMed ID: 9845927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chitosan as an adjuvant for parenterally administered inactivated influenza vaccines.
    Ghendon Y; Markushin S; Krivtsov G; Akopova I
    Arch Virol; 2008; 153(5):831-7. PubMed ID: 18297235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Variability of the sensitivity of human lymphocytes to the antiproliferative action of alkylating agents].
    Veremko LN; Telegin LIu; Pevnitskii LA
    Biull Eksp Biol Med; 1983 May; 95(5):73-5. PubMed ID: 6405824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antivirals for influenza: historical perspectives and lessons learned.
    Hayden FG
    Antiviral Res; 2006 Sep; 71(2-3):372-8. PubMed ID: 16815563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.